Fintel reports that on January 9, 2025, RBC Capital upgraded their outlook for Bank of Montreal (NYSE:BMO) from Sector ...
BMO Capital downgraded IGM Biosciences (IGMS) to Market Perform from Outperform with a price target of $2, down from $21, following the ...
Bank of Montreal closed C$5.91 short of its 52-week high of C$147.54, which the company reached on December 6th.
The yield on 10-year U.K. government debt rose to the highest since 2008, the latest casualty of a global rout spurred by ...
RBC Capital Markets upgrades Bank of Montreal and Canadian Imperial Bank of Commerce to Outperform, citing positive outlook ...